Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Marimed (MRMD) Interest & Investment Income (2018 - 2025)

Marimed (MRMD) has disclosed Interest & Investment Income for 8 consecutive years, with $25000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Interest & Investment Income changed 0.0% to $25000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $112000.0, a 8.74% increase, with the full-year FY2024 number at $114000.0, down 57.78% from a year prior.
  • Interest & Investment Income was $25000.0 for Q3 2025 at Marimed, roughly flat from $25000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $318000.0 in Q2 2022 to a low of $13000.0 in Q4 2021.
  • A 5-year average of $80289.8 and a median of $29000.0 in 2023 define the central range for Interest & Investment Income.
  • Peak YoY movement for Interest & Investment Income: skyrocketed 1738.46% in 2022, then plummeted 88.7% in 2023.
  • Marimed's Interest & Investment Income stood at $13000.0 in 2021, then surged by 1738.46% to $239000.0 in 2022, then tumbled by 88.7% to $27000.0 in 2023, then skyrocketed by 40.74% to $38000.0 in 2024, then tumbled by 34.21% to $25000.0 in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Interest & Investment Income are $25000.0 (Q3 2025), $25000.0 (Q2 2025), and $24000.0 (Q1 2025).